• share
• favorite_border

In a study of mice, researchers identified a mechanism that causes post-infection neurological problems

• share
• favorite_border

People who have an influenza infection are more likely to need medical care for neurologic disorders within the next year than people who have a COVID-19 infection, according to a study published in the March 20, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

• share
• favorite_border

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.

• share
• favorite_border

Researchers take a closer look at both the potential benefits and risks of acetaminophen, NSAIDs such as ibuprofen, as well as aspirin for the selection of OTC drugs to treat mild symptoms of COVID-19.

• share
• favorite_border

Text nudges encouraging people to get the COVID-19 vaccine, which had proven effective in prior real-world field tests, are also effective at prompting people to get a booster. The key in both cases is to include in the text a sense of ownership in the dose awaiting them.

• share
• favorite_border

New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

• share
• favorite_border

Research from the journal Risk Analysis, examined the likelihood of COVID-19 coming from an unnatural origin (i.e. from a laboratory.)

• share
• favorite_border

A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies.

• share
• favorite_border

• share
• favorite_border

Researchers at the University of Minnesota Twin Cities may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.

• share
• favorite_border

In the current climate of increased medical mistrust, survey data show sexual minority adults are more open to using COVID-19 screening and tracking tools, challenging stereotypes and highlighting the need for inclusive health care solutions.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Four years ago, a brand new virus turned the world upside down. Today, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before. A summary of the latest knowledge and guidance.

• share
• favorite_border

22 grants fund a range of innovative research and initiatives

• share
• favorite_border

A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.

• share
• favorite_border

• share
• favorite_border

Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.

• share
• favorite_border

In a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine, physician-scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine discovered that high-dose inhaled nitric oxide therapy may improve oxygenation and reduce the risk of mortality among critically ill Black patients with COVID-19.

• share
• favorite_border

For centuries, coronaviruses have triggered health crises and economic challenges, with SARS-CoV-2, the coronavirus that spreads COVID-19, being a recent example.

• share
• favorite_border

RUDN University psychologists, as part of an international scientific team, studied social representations of COVID-19 in Russia and Malaysia at the end of 2020 among young people.

• share
• favorite_border

• share
• favorite_border

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses

• share
• favorite_border

Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a University of California, Riverside, study has found.

• share
• favorite_border

New study results challenge the idea that vaccine immunity fades quickly

• share
• favorite_border

UT Battelle LLC, a management contractor for the U.S. Department of Energy’s (DOE) Office of Science, has awarded $1.2 million to Stony Brook University researchers for a study to test surface pathogen prevention.

• share
• favorite_border

A highly contagious childhood disease once eradicated by vaccination has made a comeback.

• share
• favorite_border

The University of Pennsylvania Perelman School of Medicine has received a $2.1M grant from PolyBio Research Foundation to expand long COVID research. The grant, issued via PolyBio’s Long COVID Research Consortium (LCRC), will support studies to characterize mechanisms of SARS-CoV-2 persistence in the gut, including determining the impact of viral reservoirs on gut microbiome ecosystems.

• share
• favorite_border

Funding will also support researching other complex illnesses and medical education

• share
• favorite_border

PolyBio Research Foundation today announced the second phase of its LongCovid Research Consortium (LCRC), including the distribution of $15M to fund research and clinical trials.

• share
• favorite_border

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

• share
• favorite_border

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

• share
• favorite_border

Scientists still are not sure how neurological symptoms arise in COVID-19.

• share
• favorite_border

Testing wastewater to assess the spread of the COVID-19 virus became common and well-publicized during the pandemic, but it has been focused mostly on urban areas.

• share
• favorite_border

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 — researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine and five other collaborators report that a rapid antigen test (RAT) for detecting SARS-CoV-2, the virus that causes COVID-19, can be used at home with accuracy comparable to the same test being administered by a health care professional.